A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)
Status:
Recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics, and
pharmacodynamics of VX-670 at different single and multiple doses in participants with DM1.